Serum-based protein profiles of Alzheimer's disease and mild cognitive impairment in elderly Hispanics

Neurodegener Dis Manag. 2016 Jun;6(3):203-13. doi: 10.2217/nmt-2015-0009. Epub 2016 May 27.

Abstract

Aim: To describe the biomarker profiles in elderly Panamanians diagnosed with Alzheimer's disease (AD), mild cognitive impairment (MCI) or no impairment using serum-based biomarkers.

Methods: Twenty-four proteins were analyzed using an electrochemiluminescence-based multiplex biomarker assay platform. A biomarker profile was generated using random forest analyses.

Results: Two proteins differed among groups: IL-18 and T-lymphocyte-secreted protein I-309. The AD profile was highly accurate and independent of age, gender, education and Apolipoprotein E ε4 status. AD and MCI profiles had substantial overlap among the top markers, suggesting common functions in AD and MCI but differences in their relative importance.

Conclusion: Our results underscore the potential influence of genetic and environmental differences within Hispanic populations on the proteomic profile of AD.

Keywords: Hispanic; Latin America; aging; blood-based biomarkers; cognition; dementia.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aging / blood*
  • Alzheimer Disease / blood*
  • Analysis of Variance
  • Biomarkers / blood*
  • Blood Proteins / metabolism*
  • Chi-Square Distribution
  • Cognition Disorders / blood*
  • Cohort Studies
  • Cytokines / blood*
  • Disease Progression
  • Female
  • Hispanic or Latino
  • Humans
  • Male
  • Psychiatric Status Rating Scales

Substances

  • Biomarkers
  • Blood Proteins
  • Cytokines